211 related articles for article (PubMed ID: 32313931)
21. The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.
Vandeweyer G; Van der Aa N; Reyniers E; Kooy RF
Am J Hum Genet; 2012 Jun; 90(6):1071-8. PubMed ID: 22608712
[TBL] [Abstract][Full Text] [Related]
22. A role for transcription factor GTF2IRD2 in executive function in Williams-Beuren syndrome.
Porter MA; Dobson-Stone C; Kwok JB; Schofield PR; Beckett W; Tassabehji M
PLoS One; 2012; 7(10):e47457. PubMed ID: 23118870
[TBL] [Abstract][Full Text] [Related]
23. GTF2IRD1 regulates transcription by binding an evolutionarily conserved DNA motif 'GUCE'.
Thompson PD; Webb M; Beckett W; Hinsley T; Jowitt T; Sharrocks AD; Tassabehji M
FEBS Lett; 2007 Mar; 581(6):1233-42. PubMed ID: 17346708
[TBL] [Abstract][Full Text] [Related]
24. The early embryonic expression of TFII-I during mouse preimplantation development.
Enkhmandakh B; Bitchevaia N; Ruddle F; Bayarsaihan D
Gene Expr Patterns; 2004 Jan; 4(1):25-8. PubMed ID: 14678824
[TBL] [Abstract][Full Text] [Related]
25. Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.
Hinsley TA; Cunliffe P; Tipney HJ; Brass A; Tassabehji M
Protein Sci; 2004 Oct; 13(10):2588-99. PubMed ID: 15388857
[TBL] [Abstract][Full Text] [Related]
26. ChIP-Chip Identifies SEC23A, CFDP1, and NSD1 as TFII-I Target Genes in Human Neural Crest Progenitor Cells.
Makeyev AV; Bayarsaihan D
Cleft Palate Craniofac J; 2013 May; 50(3):347-50. PubMed ID: 23145914
[TBL] [Abstract][Full Text] [Related]
27. Essential role of the N-terminal region of TFII-I in viability and behavior.
Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
[TBL] [Abstract][Full Text] [Related]
28. Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23.
Franke Y; Peoples RJ; Francke U
Cytogenet Cell Genet; 1999; 86(3-4):296-304. PubMed ID: 10575229
[TBL] [Abstract][Full Text] [Related]
29. An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter.
Huo Y; Su T; Cai Q; Macara IG
Cell Rep; 2016 Jun; 15(10):2089-2096. PubMed ID: 27239038
[TBL] [Abstract][Full Text] [Related]
30. Multiple GTF2I-like repeats of general transcription factor 3 exhibit DNA binding properties. Evidence for a common origin as a sequence-specific DNA interaction module.
Vullhorst D; Buonanno A
J Biol Chem; 2005 Sep; 280(36):31722-31. PubMed ID: 15987678
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterisation of GTF2IRD2, a novel fusion gene and member of the TFII-I family of transcription factors, deleted in Williams-Beuren syndrome.
Tipney HJ; Hinsley TA; Brass A; Metcalfe K; Donnai D; Tassabehji M
Eur J Hum Genet; 2004 Jul; 12(7):551-60. PubMed ID: 15100712
[TBL] [Abstract][Full Text] [Related]
32. GTF2IRD1 in craniofacial development of humans and mice.
Tassabehji M; Hammond P; Karmiloff-Smith A; Thompson P; Thorgeirsson SS; Durkin ME; Popescu NC; Hutton T; Metcalfe K; Rucka A; Stewart H; Read AP; Maconochie M; Donnai D
Science; 2005 Nov; 310(5751):1184-7. PubMed ID: 16293761
[TBL] [Abstract][Full Text] [Related]
33. TFII-I and AP2α Co-Occupy the Promoters of Key Regulatory Genes Associated with Craniofacial Development.
Miranda P; Enkhmandakh B; Bayarsaihan D
Cleft Palate Craniofac J; 2018 Jul; 55(6):865-870. PubMed ID: 28085512
[TBL] [Abstract][Full Text] [Related]
34. The contribution of GTF2I haploinsufficiency to Williams syndrome.
Chailangkarn T; Noree C; Muotri AR
Mol Cell Probes; 2018 Aug; 40():45-51. PubMed ID: 29305905
[TBL] [Abstract][Full Text] [Related]
35. The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation.
Carmona-Mora P; Widagdo J; Tomasetig F; Canales CP; Cha Y; Lee W; Alshawaf A; Dottori M; Whan RM; Hardeman EC; Palmer SJ
Hum Genet; 2015 Oct; 134(10):1099-115. PubMed ID: 26275350
[TBL] [Abstract][Full Text] [Related]
36. Integration of a c-myc transgene results in disruption of the mouse Gtf2ird1 gene, the homologue of the human GTF2IRD1 gene hemizygously deleted in Williams-Beuren syndrome.
Durkin ME; Keck-Waggoner CL; Popescu NC; Thorgeirsson SS
Genomics; 2001 Apr; 73(1):20-7. PubMed ID: 11352562
[TBL] [Abstract][Full Text] [Related]
37. Consistent hypersocial behavior in mice carrying a deletion of
Martin LA; Iceberg E; Allaf G
Brain Behav; 2018 Jan; 8(1):e00895. PubMed ID: 29568691
[TBL] [Abstract][Full Text] [Related]
38. Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice.
Young EJ; Lipina T; Tam E; Mandel A; Clapcote SJ; Bechard AR; Chambers J; Mount HT; Fletcher PJ; Roder JC; Osborne LR
Genes Brain Behav; 2008 Mar; 7(2):224-34. PubMed ID: 17680805
[TBL] [Abstract][Full Text] [Related]
39. Biallelic GTF2IRD1 variants in brothers with profound neurodevelopmental disorder: A possible novel disorder involving a critical gene for Williams syndrome.
Cummings CT; Starr LJ
Am J Med Genet A; 2023 Feb; 191(2):332-337. PubMed ID: 36308390
[TBL] [Abstract][Full Text] [Related]
40. Identification of the TFII-I family target genes in the vertebrate genome.
Chimge NO; Makeyev AV; Ruddle FH; Bayarsaihan D
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9006-10. PubMed ID: 18579769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
